In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
Related Posts
Trump’s Tariffs Are Damaging America’s Biggest Foreign Source of Screws
Taiwan has long been the top provider of screws to the United States. But its factories are struggling to survive…
Nvidia Is Hosting the Super Bowl of A.I.
The giant chipmaker has transformed its annual developer conference from an academic event into a who’s who gathering for the…
A.I. and Vibecoding Helped Me to Create My Own Software
I’m not a programmer. But I’ve been creating my own software tools with help from artificial intelligence.